There is a **varied outlook** on Colgate-Palmolive Company (CL) from Wall Street with views ranging from **bullish** to **bearish**. The company's stock has experienced periods of **underperformance** compared to its competitors but has also seen days of **outperformance**. Strategically, the company appears strong, and their **dividend** offering has been deemed attractive. The stock climbed over **15%** this year, leading to questions of further growth. Analysts raised their price target for CL to $107. Analysts and investors consider Colgate-Palmolive a solid **growth** stock and recognize it as a steady performer. The company had robust Q1 2024 performance and outpaced analyst revenue forecasts. The company cleared soaring profits and sales, especially in India. Despite some investors suffering a loss of 6.6% on their investment three years ago, investing five years ago would have yielded a 51% gain. Colgate-Palmolive is expected to **increase its dividend to $0.50**. The company also continues to show promise in the momentum stock category, delivering a **strong Q4 earnings result** that surpassed estimates. However, the company seems to be sensible in its use of debt, even as an executive sold over $2M of company stock.
Colgate-Palmolive Company CL News Analytics from Thu, 12 Oct 2023 07:00:00 GMT to Thu, 23 May 2024 17:11:00 GMT -
Rating 5
- Innovation 4
- Information 7
- Rumor -3
